Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price raised by BMO Capital Markets from $385.00 to $389.00 in a report released on Wednesday, Benzinga reports. They currently have an outperform rating on the pharmaceutical company’s stock. Other equities analysts have also recently issued reports about the company. Bank of America boosted their price […]
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $352 00 at Morgan Stanley themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Howland Capital Management LLC bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm bought 1,146 shares of the pharmaceutical company’s stock, valued at approximately $361,000. A number of other hedge funds and other institutional investors have also […]
Gilbert & Cook Inc. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 28.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,174 shares of the pharmaceutical company’s stock after buying an additional 262 shares during the quarter. Gilbert & […]